VCEL (Vericel) Other Operating Expense: $-0.0 Mil (TTM As of Mar. 2026)


VCEL Vericel Corp VCEL
81 GF Score
Price $46.98
GF Value $54.64
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Vericel Other Operating Expense?

Vericel VCEL +4.05% 81 Other Operating Expense is $-0.0 Mil as of Mar. 2026. GuruFocus rates VCEL with a GF Score™ of 81/100 and a GF Value™ of $54.64 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Vericel's Other Operating Expense for the three months ended in Mar. 2026 was $0.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.0 Mil.

Vericel's annual Other Operating Expense increased from Dec. 2023 ($-0.0 Mil) to Dec. 2024 ($0.0 Mil) but then stayed the same from Dec. 2024 ($0.0 Mil) to Dec. 2025 ($0.0 Mil).

Vericel Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Vericel's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vericel Other Operating Expense Chart

Vericel Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.00 0.00 0.00

Vericel Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 0.00
VCEL
81GF Score
Vericel Corp VCEL
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vericel Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $-0.0 Mil mean?
Vericel (VCEL) has a Other Operating Expense of $-0.0 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Vericel and its competitors.
Is Vericel's Other Operating Expense too high?
Vericel's current Other Operating Expense is $-0.0 Mil. Overall, Vericel has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vericel's Other Operating Expense compare to NRIX and MLYS?
Vericel's Other Operating Expense of $-0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Vericel and its competitors. Vericel's current Other Operating Expense is $-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vericel stock overvalued right now?
Based on GuruFocus' analysis, Vericel (VCEL) is currently considered Modestly Undervalued. The stock's GF Value™ is $54.64, compared to a current price of $46.98 — trading 14% below its estimated fair value. The current Other Operating Expense is $-0.0 Mil. Vericel's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Vericel (VCEL), the current Other Operating Expense is $-0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vericel (VCEL) Overvalued in 2026?

Based on GuruFocus' analysis, Vericel stock appears to be undervalued. The current stock price of $46.98 is trading 14% below its estimated GF Value™ of $54.64. GuruFocus considers Vericel to be Modestly Undervalued.

Key valuation signals for VCEL:

  • Other Operating Expense: $-0.0 Mil
  • GF Value™: $54.64 vs. price of $46.98 (14% below fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the VCEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vericel Business Description

Other Exchanges ATQP:Germany
Address 64 Sidney Street, Cambridge, MA, USA, 02139
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
81GF Score

Get the complete analysis for VCEL

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$46.98
Price
$54.64
GF Value